Evidence map›Paper›PMID 40240530›Full record

ArticleJournal of autism and developmental disorders2026

Novel CTNNB1 Gene Variants in Spanish CTNNB1 Syndrome Patients: Clinical and Psychological Manifestations.

Mercè Pallarès-Sastre, Imanol Amayra, Rafael Pulido, Caroline E Nunes-Xavier, Sonia Bañuelos, Fabio Cavaliere, Maitane García

Abstract read
In one paragraph

Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Frontiers in neurology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mercè Pallarès-SastreNeuro-e-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de las Universidades 24, Deusto, 48007, Bilbao, Spain. m.pallares@deusto.es.ORCID http://orcid.org/0009-0000-2386-3595
Imanol AmayraNeuro-e-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de las Universidades 24, Deusto, 48007, Bilbao, Spain.ORCID https://orcid.org/0000-0002-3250-628X
Rafael PulidoBiobizkaia Health Research Institute, Barakaldo, Spain.ORCID https://orcid.org/0000-0001-9100-248X
Caroline E Nunes-XavierBiobizkaia Health Research Institute, Barakaldo, Spain.ORCID https://orcid.org/0000-0002-1875-6645
Sonia BañuelosBiofisika Institute (UPV/EHU, CSIC), University of the Basque Country (UPV/EHU), Leioa, Spain.ORCID https://orcid.org/0000-0002-1399-381X
Fabio CavaliereBiofisika Institute (UPV/EHU, CSIC), University of the Basque Country (UPV/EHU), Leioa, Spain.ORCID https://orcid.org/0000-0003-2003-522X
Maitane GarcíaNeuro-e-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de las Universidades 24, Deusto, 48007, Bilbao, Spain.ORCID https://orcid.org/0000-0003-0895-1751

Funding

Fundación Inocente, Inocente FII2024-69Ministerio de Ciencia, Innovación y Universidades FPU22/00391
6 · The paper itself

Abstract

CTNNB1 Syndrome is a neurodevelopmental disorder caused by de novo pathogenic variants characterized by global cognitive impairment, microcephaly, speech and motor delay, abnormal muscle tone, ophthalmologic impairments, behaviour problems and autistic spectrum disorder (ASD) symptoms. The aim of this study is to carry out a thorough clinical and psychological characterization of Spanish CTNNB1 syndrome patients. We used standard clinical assessment instruments and an ad hoc questionnaire to measure motor functioning, neurodevelopmental milestones, sleep problems, daily life activities, behavioural problems, communication and speech impairments, eating disorders and autistic features in 25 participants with CTNNB1 syndrome (15 females, 10 males; mean age 7.1 ± 4.1). Main clinical manifestations reported were microcephaly, motor impairment, sight problems, sleep disturbances and sensorial problems. Attainment of developmental milestones indicated motoric, language and daily living skills to be generally delayed. All participants had adaptative skills below their chronological age, even though verbal individuals had better functioning compared to nonverbal. Regarding behaviour impairments, CTNNB1 syndrome patients scored significantly high at internalizing and externalizing behavioural problems. Additionally, about 60% presented symptoms of ASD. Our findings have important implications for the psychotherapeutic and clinical approaches of CTNNB1 syndrome patients. We show the importance of early stimulation, given that an early attainment of developmental milestones is related to a current better function of many clinical variables. Moreover, previous underrated symptoms such as sleep problems, impaired adaptative skills and high rates of behavioural symptoms should be taken into consideration due to the harmful impact that have on every day life.

Indexed as

Autism Spectrum Disorderbeta CateninDevelopmental DisabilitiesNeurodevelopmental DisordersAdolescentChildChild, PreschoolFemaleHumansMaleSpainSyndromebeta CateninCTNNB1 protein, humanAutism spectrum disorderBehavioural problemsCTNNB1 syndromeDevelopmental delayMotor impairmentsRare disease

Identifiers

PMID40240530
PMCPMC13427793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.